3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
27
Breast Neoplasms
23
Neoplasm Metastasis
14
Glioma
14
Carcinoma, Non-Small-Cell Lung
14
Lymphoma
12
Lung Neoplasms
11
Glioblastoma
11
Neuroblastoma
10
Lymphoma, Non-Hodgkin
9
Carcinoma, Renal Cell
9
Brain Neoplasms
9
Medulloblastoma
8
Ovarian Neoplasms
7
Neoplasms
7
Multiple Myeloma
7
Ependymoma
7
Carcinoma, Hepatocellular
7
Wilms Tumor
6
Thyroid Neoplasms
6
Sarcoma
6
Rectal Neoplasms
6
Pancreatic Neoplasms
6
Osteosarcoma
6
Melanoma
6
Fallopian Tube Neoplasms
6
Central Nervous System Neoplasms
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Interventions
pembrolizumab
2
fludarabine phosphate
2
fludarabine
2
aldesleukin
2
Cyclophosphamide
2
rocakinogene sifuplasmid
1
durvalumab
1
VGX-3100
1
Surveys and Questionnaires
1
Sildenafil Citrate
1
Paclitaxel
1
MEDI0457
1
Interleukin-2
1
Immunoglobulin G
1
Ifosfamide
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Fentanyl
1
Disulfides
1
Cisplatin
1
Alprostadil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Penile Neoplasms
×
Magnetic Resonance Spectroscopy
×
Clear all
No trials found.